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Abstract 
Mechanistic computational models enable the study of regulatory mechanisms 
implicated in various biological processes. These models provide a means to ana-
lyze the dynamics of the systems they describe, and to study and interrogate their 
properties, and provide insights about the emerging behavior of the system in the 
presence of single or combined perturbations. Aimed at those who are new to 
computational modeling, we present here a practical hands-on protocol breaking 
down the process of mechanistic modeling of biological systems in a succession of 
precise steps. The protocol provides a framework that includes defining the model 
scope, choosing validation criteria, selecting the appropriate modeling approach, 
constructing a model and simulating the model. To ensure broad accessibility of the 
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protocol, we use a logical modeling framework, which presents a lower mathemati-
cal barrier of entry, and two easy-to-use and popular modeling software tools: Cell 
Collective and GINsim. The complete modeling workflow is applied to a well-studied 
and familiar biological process—the lac operon regulatory system. The protocol can 
be completed by users with little to no prior computational modeling experience 
approximately within 3 h. 
Keywords: mechanistic logic-based models, in silico simulations, lac operon, 
computational systems biology, Cell Collective, GINsim  
Introduction 
Published manuscripts, textbooks and presentations often use illus-
trations and static diagrams of biological networks to represent and 
communicate complex biological processes and mechanisms. Creat-
ing such illustrations of biological pathways facilitates the systematic 
synthesis of prior knowledge to represent comprehensively and accu-
rately a given biological process. Nevertheless, no matter how precise 
and detailed, a static graph can only provide a limited amount of in-
formation about a system. However, living organisms and their build-
ing blocks (e.g. cells, tissues and organs) are dynamic systems that 
respond and adapt continuously to different situations and various 
stimuli [1, 2]. Mechanistic computational models can add this ‘third 
dimension’ of dynamics to our methods for understanding complex 
biological systems. Modeling the dynamics of biological networks has 
been a significant challenge in life sciences, and systems biology has 
seen a flourish of development and application of methods over the 
past decades.  
Applications of the protocol 
Dynamical analyses and simulations of computational models enable 
researchers to predict, characterize and explain complex behaviors of a 
biological system under various scenarios such as gene knock-outs or 
other types (even combinations) of perturbations. Such modeling ef-
forts have the potential to contribute to experimental design through 
better prioritization of hypotheses (targets) and lead to considerable 
time and resource savings. Computational modeling also offers the 
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potential to bring together researchers with different expertise, includ-
ing wet lab experimentalists, translational researchers,  clinicians, com-
puter scientists, mathematicians and bioinformaticians. However, in 
order to reach this potential, computational modeling must be made 
available in an environment accessible to people without prior compu-
tational experience while offering powerful and comprehensive tools 
to expert modelers. Modern biology is awash with data; laboratory 
scientists must be able to use cutting-edge computational approaches 
to manipulate, visualize, model and simulate such data without the 
need for external expertise [3–8]. In bioinformatics, easy-to-use plat-
forms such as Galaxy [9] brought powerful analysis methods within 
reach of wet-lab researchers, allowing non-bioinformaticians to ana-
lyze large genomics and functional genomics datasets, thus signifi-
cantly increasing the impact of bioinformatics research. 
Construction and analysis of computational models can be a daunt-
ing task, involving the use of software tools that require advanced bio-
informatic and/or mathematical skills. Several education institutions 
and grant-funding agencies in the USA and Europe have recognized 
that systems modeling, numerical simulations and understanding 
dynamics are skills currently lacking across the life sciences educa-
tion system. This is despite the need by the next generation of the 
life sciences workforce to be prepared and succeed in today’s and 
tomorrow’s health and life sciences jobs [10–12]. Indeed, mechanistic 
modeling (in particular logical modeling as used in this protocol) is 
already used as an active, inquiry-based learning approach, whereby 
university life sciences students can learn about the various biologi-
cal and biochemical processes by building, simulating and analyzing 
relevant computational models [13–16]. 
Overview 
We designed this protocol to address computational and mathemati-
cal barriers that hinder non-computational scientists from efficiently 
incorporating computational modeling into their experimental prac-
tices. This protocol provides the audience with a conceptual f low of 
the modeling process (Figure 1): designing the scope of a model, 
defining the model’s validation criteria, selecting an appropriate mod-
eling approach, building and annotating the model and analyzing its 
dynamics. It is important to note that the process of modeling, like 
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any scientific research, does not follow a linear path. It is important 
to expect that each step of the process outlined in this protocol (and 
Figure 1) can (and likely will) result in the need to revise previous 
steps to account for unexpected pieces of knowledge obtained while 
constructing or simulating the model. For example (Figure 1), a re-
searcher might decide to fine-tune the regulatory mechanism (step 
5) after model validation did not produce satisfactory results. In an-
other scenario, a researcher may realize the model that is not passing 
a validation criterion because the model did not consider a critical 
pathway; in this case, they need to identify additional components 
and interactions (step 4) or re-define the validation criterion to better 
align with model scope (step 2). 
Review of the lac operon regulation system 
This protocol is designed to be broadly accessible to biology scientists, 
established or in-training. As such, no prior training or experience in 
computational modeling, programming or bioinformatics is needed. 
Throughout the protocol, we use the widely studied and well-known 
lac operon system.   
As detailed in Figure 2, the lac operon includes a set of three genes: 
a promoter, a regulator and an operator. The three structural genes 
are lacZ, encoding β-galactosidase, an enzyme able to metabolize 
Figure 1. An overview flowchart depicting the process of modeling. Solid arrows 
indicate the main workflow. Dotted arrows indicate possible needs for the revision 
of previous steps, as discussed in the main text.   
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Figure 2. Overview of lac operon regulation. See main text for details about the 
regulation of the lac operon. The lac operon is under the control of two regulatory 
molecules, the lac repressor and the CAP. These molecules are responsible for switch-
ing the lac operon ON or OFF, depending on sugar availability. In the absence of 
extracellular glucose (depicted with degradation circles), the hunger molecule cAMP 
(blue node) binds to CAP (green node) and stabilizes a conformation with a high 
affinity for the regulator CAP site of DNA (depicted with a green box with a cross). 
The cAMP-CAP binding favors the binding of the RNA polymerase (orange node) 
to the promoter (thick black arrow) site. This also happens because, as extracellular 
lactose (depicted with pale orange nodes) is imported into the cell, a fraction of it 
is converted to allolactose (green nodes). Allolactose binds to the lac repressor (big 
purple node), stabilizing a conformation unable to bind the operator (orange box 
with a black minus). RNA polymerase is thus free to start transcribing the operon. 
When the operon is active, the three structural genes will be produced, namely 
lacZ, lacY and lacA. LacI, the gene encoding for the lac repressor, is not part of the 
operon and is under the control of its own promoter. lacI is continuously transcribed 
and the repressor protein is always present. The lac repressor binds to the operator, 
which is partially overlapping with the promoter region. This binding prevents the 
RNA polymerase from binding and starting the transcription process. Illustration 
was created with TinkerCell (http://www.tinkercell.com). 
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lactose into glucose and galactose, lacY, encoding β-galactoside per-
mease, a transmembrane protein that imports β-galactosides into the 
cell, and lacA, which encodes the β- galactoside transacetylase, an 
enzyme responsible for the transfer of an acetyl group from acetyl-
CoA to β-galactosides. LacA does not actively participate in lactose 
metabolism [17, 18]. 
The lac operon is controlled by two regulatory molecules: the lac 
repressor and the catabolite activator protein (CAP). These molecules 
are responsible for switching the lac operon ON or OFF, depending 
on sugar availability. 
The lac repressor binds to the operator, which is partially over-
lapping with the promoter region. This binding prevents the RNA 
polymerase from binding and starting the transcription process. LacI, 
the gene that encodes the lac repressor, is not part of the operon 
and is controlled by its own promoter. LacI is continually transcribed, 
and the repressor protein is always present. As lactose enters a cell, 
a fraction of it is converted into the inducer allolactose, an isomer of 
lactose. Allolactose binds to the lac repressor, stabilizing a conforma-
tion that is unable to bind the operator. RNA polymerase is thus free 
to start transcribing the operon. When glucose levels are low, CAP 
can bind to a site just upstream to the lac operon, the regulator, and 
facilitates the RNA polymerase attachment to the promoter. The gene 
that encodes CAP is not part of the lac operon and is constitutively 
expressed. The binding of CAP to the DNA is regulated by the ‘hunger 
signal’ molecule, cyclic adenosine monophosphate (cAMP), which is 
produced in Escherichia coli when glucose levels are low. cAMP binds 
to CAP and stabilizes a conformation with a high affinity for the regu-
lator [19]. In the absence of binding of the cAMP-CAP complex to the 
DNA, transcription of the operon is significantly reduced [18, 20, 21]. 
Thus, the operon is transcribed at a high level only when glucose, the 
preferred sugar, is absent. E. coli cells presented with a mix of glucose 
and lactose will induce the lac operon only after the glucose has been 
depleted [22]. 
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Requirements 
Equipment 
A computer with a Windows, Mac or Linux operating system, Internet 
connection and a web browser with WebGL enabled. The hardware 
specifications of the computer may limit the size of models that can 
be analyzed within GINsim. We recommend a computer with 4+ GB 
of RAM and a dual-core processor, in which case use Cell Collective. 
Equipment setup 
Cell Collective is a web-based application, which does not require 
installation on one’s computer. Users need to create a (free) account 
directly in Cell Collective at https://cellcollective.org (under the ‘Re-
search’ panel). Further user support is available via email at support@
cellcollective.org. 
GINsim can be downloaded from http://ginsim.org. The reader 
should make sure to download version 2.9 or higher, as older versions 
do not support the import of SBML-encoded models. They should 
also ensure that they have Java 1.6 or above installed. Open the down-
loaded file and follow the installation instructions. 
Step 1: Define the scope of the modeled system 
The first step of a modeling project is often to decide the scope of 
the model. Biological networks can be vast, complex and span sev-
eral scales of biological organization (from molecules to cells, tis-
sues, organisms and even populations). It is critical to understand that 
computational models are simplifications or abstractions of the real 
biological system. As such, it is essential to define a model scope that 
encompasses the minimum number of elements (e.g. pathways) able 
to address our research question with the data at hand. One can also 
think of the scope of the modeled system as boundaries defined by 
the system’s input (e.g., stimuli) and output (e.g., modeled phenom-
enon and its ‘biomarkers’). 
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In this protocol, we focus on the lac operon system, one of the first 
gene regulatory mechanisms to be fully elucidated and characterized 
[17]. The lac operon is responsible for regulating lactose metabolism 
in E. coli and other enteric bacteria. Lactose provides the bacterium 
with an alternative source of carbon when glucose is not present. 
As such, the scope of the modeled system can be defined by the 
availability of extracellular glucose and lactose as inputs/stimuli, and 
lactose metabolism as the model output. As mentioned above, it is 
important to realize that building a mechanistic computational model 
is an iterative process, which means that the scope can be adjusted 
as needed during the entire modeling process.   
Step 2: Define validation criteria 
One way to assess whether a computational model might be able to 
answer a given research question, validation criteria should be de-
fined. These criteria will ensure that the constructed model behaves 
as expected within the model scope defined in Step 1. 
Quantitative or qualitative relationships between input(s) and 
output(s) can constitute validation criteria for computational models. 
In the case of the lac operon, they can be the relationships between 
lactose and glucose (inputs) and the lac operon expression (output), 
because these relationships are well-documented, understood and 
within the scope of the model. Table 1 presents the four validation 
criteria, i.e. all possible combinations of the presence and absence of 
lactose and glucose and the output that the model should produce 
to be considered useful and correct within this scope. 
Table 1. Validation criteria for the modeled lac operon system 
 Glucose  Lactose  lac operon transcription 
Validation criterion 1  present  absent  OFF 
Validation criterion 2  present  present  OFF 
Validation criterion 3  absent  present  ON 
Validation criterion 4  absent  absent  OFF  
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Step 3: Select modeling approach 
Once the modeler has decided on the scope and validation criteria, 
the second step is to select an appropriate modeling technique. Many 
mathematical and computational frameworks are available to model 
biological mechanisms and processes. Interested readers should re-
view [23, 24] for detailed summaries of various modeling techniques. 
Examples include logical models [25], kinetic models (e.g. via ordinary 
differential equations; ODEs [26]), constraint-based models [27], etc. 
It is essential to understand that every modeling approach makes 
different assumptions, and comes with different requisites and con-
straints and therefore presents different benefits and limitations. Un-
derstanding the type of questions that a given computational model 
can answer is critical, as is the type and amount of data needed to 
construct and interpret the model. For example, ODE models are very 
useful to generate quantitative predictions. However, their reliance 
on kinetic parameters and the required computational complexity 
and cost limit their usefulness to well-characterized, relatively small, 
networks/pathways. ODE-based modeling also generally requires a 
steep learning curve as it relies on complex mathematical equations 
that describe the system’s kinetics. [24] Constraint-based models are 
based on the stoichiometry of reactions and are used to calculate 
optimal flux distributions in metabolic networks [27]. 
The protocol presented here uses a logical modeling framework. 
Researchers use this approach to study the dynamics of many biologi-
cal processes and diseases (e.g. T cell differentiation [2], renovascular 
disease [28], patient-specific signaling pathways in cancer [29], hu-
man immune system [30]), primarily because of its accessible nature. 
Logical modeling approaches are well suited for qualitative biological 
problems such as cell fates arising under certain initial conditions or 
the pathways affected by the perturbation of a particular gene or pro-
tein [25, 31, 32]. Like any other approach, logical modeling presents 
its own limitations. For example, attractors (see Box 1) are computa-
tionally expensive to compute due to the exponential growth of the 
models’ state space. Logical model output is generally discrete, which 
may be insufficient if one needs to quantify specific concentrations. 
For a recent and comprehensive review of logical modeling and its 
broad areas of application, readers should consider [25]. However, 
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the increasing popularity of logical models is also due to, among 
other reasons, their independence from the scarce availability of ki-
netic parameters, their scalability and the opportunity they offer for 
in-depth dynamical analysis while retaining the ability to describe 
biological processes at the mechanistic level. Moreover, logical models 
are generally more accessible to a non-modeling audience because 
their ‘logic-based’ ‘nature closely resembles the language used to de-
scribe regulatory mechanisms in wet-lab research publications and the 
qualitative nature of phenotypic matrices obtained in many genetic 
screens. The logical rules describing various biological mechanisms 
are relatively easily applied to construct and ‘read’ the underlying 
mechanistic computational models [33], lending itself as an intuitive 
interface between biology and computational modeling. Recent ef-
forts building on these advantages are speeding up the building of 
large, accurate, and simulatable logical models from comprehensive 
disease maps [34] and high-throughput data [35]. 
Box 1: Introduction to logical modeling 
Logical models are composed of components (nodes) connected 
with directed edges (Figure 3). The individual components of the 
system can correspond to proteins, complexes, transcription fac-
tors, genes or more abstract phenomena such as cellular fates. 
The directed edges represent causal (direct or indirect) interac-
tions between these components denoting negative influences 
(e.g. inhibitions, repressions and degradations) or positive ones 
(e.g. stimulations, activations and synthesis). Logical models can 
be Boolean or multi-valued. In Boolean models, each component 
can be either active/expressed/ON (1) or inactive/silent/ OFF (0).
Multi-valued logical models can assume additional activity val-
ues, such as ‘OFF’, ‘medium’ and ‘ON’. The underlying regulatory 
mechanisms are described by logical expressions that determine 
the activity level of a component, given the activity states of its 
direct regulators. 
As an example, consider the hypothetical 4-component logi-
cal model in Figure 3. Open arrowheads represent positive in-
fluences, and bars represent negative ones. In this network, ‘In 
(input)’ is an external component, able to stimulate the model. In 
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general, components that are not regulated by other components 
are considered inputs, and their activity is not decided by logical 
functions. Instead, their activity level(s) can be set before or dur-
ing a simulation by the user. Conversely, the activity level of each 
remaining component is determined by their immediate regula-
tors with logical functions reflecting the regulatory mechanisms. 
For example, the logical function representing the mechanisms 
regulating Y captures a scenario where Y will be activated at any 
time point (t+1) when either X or Z was active at the previous 
time point (t). Furthermore, components, such as Y, that do not 
affect the activity level of any other components can be consid-
ered outputs (note that model outputs can also be the combina-
tion of several components’ activities). 
The model’s dynamics depend on the iterative updating of 
each component’s activity levels. Simulations of logical models 
can be synchronous (all components are updated at each time 
point) or asynchronous (components are updated according to 
a probability or a user-defined priority schema). One can study 
the dynamics of logical models as they evolve in time, or when 
the model reaches a steady-state or a set of states (‘attractors’). 
The purpose of this protocol is to introduce the general workflow 
of mechanistic modeling and not the intricacies of the logical 
modeling framework. Readers interested in learning more on the 
subject (such as the implications of synchronous versus asynchro-
nous updating or state-space analyses) can do so in numerous 
dedicated publications [36–38]. 
Figure 3. Hypothetical logical model.
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Introduction to Cell Collective and GINsim 
Because of the increasing popularity of logical modeling in biology, 
many software tools are available to the community. Some commonly 
used tools include Cell Collective, CellNOpt, GINsim, BoolNet and 
BooleanNet [25]. In this protocol, we use Cell Collective and GIN-
sim. Cell Collective is a web-based platform that allows users to build 
and use models without specifying mathematical equations or com-
puter code—addressing one of the major hurdles with computational 
modeling [39, 40]. As of today, Cell Collective supports logical- and 
constraint-based [27] modeling approaches. Users can collaboratively 
construct models, share them directly with others, and simulate and 
analyze the models in real-time on the web without the need for lo-
cal software installation and configuration. In addition, Cell Collective 
provides a database of ~80 curated logical models and nearly 200 
genome-scale metabolic models across many biological processes 
and species. We will introduce Cell Collective in an interactive and 
just-in-time fashion throughout the protocol. At the moment, the 
reader should create a free account in Cell Collective at https://www.
cellcollective.org. 
We will also use GINsim[41], a logical-modeling software that pro-
vides a variety of methods for in-depth dynamical analysis of model 
properties. In addition to Boolean models, GINsim supports models 
with multi-valued variables. The reader can download and install the 
latest version from http://ginsim.org. While in this protocol, we will 
focus on the complementary capabilities of GINsim, a complete tuto-
rial for the tool can be found in [41]. 
Let’s begin by capturing the scope of the system (defined in the In-
troduction section) through a model in Cell Collective (Procedure 1). 
Procedure 1: Model scope implementation in Cell Collective. 
1) Sign into Cell Collective (https://cellcollective.org). 
2) Click on ‘New Model’. 
3) Name the model ‘Lac Operon Tutorial’. 
4) Given the scope of the model defined previously, the first com-
ponents that can be added to the model are the inputs (‘glu-
cose’ and ‘lactose’) and the model output, ‘lactose metabolism. 
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In the ‘Graph’ panel, add these three components by double-
clicking anywhere in the panel (Figure 4). Components can be 
also added by clicking on the ‘plus’ icon in the ‘Internal’ and 
‘External Components’ panels. 
5) To designate a component as an ‘External Component’ (input), 
drag the component from the Internal Components panel to 
the External Components panel (its heading). In our example, 
‘glucose’ and ‘lactose’ are inputs to the system and are set as 
External Components in Cell Collective. ‘lactose metabolism’ is 
an internal component of the model, regulated by other system 
components (as we will see later in this protocol). 
Figure 4. Adding input and output components in Cell Collective. Yellow dots in 
the ‘Graph’ panel denote external components or inputs, which are components 
without upstream regulators, and whose activity is controlled by the user. Gray dots 
correspond to internal components of the model, whose activity is regulated by 
another model component.    
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Step 4: Identify components and their interactions, and build a 
draft model 
Once the modeler has defined the initial scope of the model and 
identified the preferred modeling approach (and the corresponding 
tool), the next step is to identify the individual components that will 
constitute the system and their interactions, and begin construct-
ing a draft of the model. This requires listing the biological entities 
they want to include in the model and also make a decision on the 
granularity of representation for each of them. During the first itera-
tion of the modeling process, the knowledge of the researcher can be 
complemented with static diagrams from published literature, or by 
accessing public databases. Review articles generally provide lists (and 
descriptions) of the most important and well-studied components of 
the reviewed biological processes, which can be used to identify the 
components that are most relevant to the modeled process. In addi-
tion, these reviews often synthesize the discussed components and 
interactions in diagrams that can be easily depicted and converted 
into a network diagram, which can further provide the basis of the 
first draft of the mechanistic model. 
Public databases such as KEGG Pathway [42], REACTOME [43], Path-
way Commons [44], PANTHER [45], WikiPathways [46], Omnipath [47], 
BioCyc [48] and Signor [49] constitute an important source of bio-
logical knowledge presented in the form of pathways or networks. 
PathGuide [50] contains information about 670 such resources related 
to biological pathways and molecular interactions. These are further 
complemented by commercial tools such as Ingenuity Pathway Analy-
sis or METACORE [51] that also provide curated canonical pathways. 
Other databases such as Genemania [52], STRING [53], IntAct [54] and 
BioGRID [55] offer information about individual reported protein–
protein interactions (inferred or experimentally validated) that can 
complement or validate a biological pathway. Many of the aforemen-
tioned resources can be easily used to develop the draft mechanistic 
representation of the system of interest and even provide their data in 
a standard format that can be directly re-used by modeling software 
tools. To make this protocol self-contained and allow the reader to 
follow easily, we have synthesized the required biological knowledge 
about the lac operon in the Introduction section and in Figure 2.   
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Now that we have defined the scope (Step 1) and the validation 
criteria (Step 2; Table 1) of the model and have defined the system 
components and their interactions, we can build a draft model. In Step 
3, we already created a model in Cell Collective with three compo-
nents (‘lactose’, ‘glucose’ and ‘lactose metabolism’) representing the 
inputs and output of the model. We will now represent the biological 
knowledge about the lac system (summarized as a network diagram 
composed of nodes and directed edges Procedure 2). Because Cell 
Collective automatically translates the diagram into logical rules, the 
initial network diagram will also become the first draft of a simulatable 
model that we will further fine-tune in the next section. 
Procedure 2: Building a draft model. 
Return to the Lac Operon Tutorial model you started in Cell Col-
lective under Procedure 1. 
Under the ‘Model’ tab, by double-clicking in the Graph panel, 
add four components of the Lac operon system identified in Step 
4: cAMP, CAP, allolactose and lac repressor. We assume that the 
amount of lac repressor is constant and omit LacI and the lac 
repressor mRNA from the model. Instead, we will focus on cap-
turing the regulatory mechanism of a functional lac repressor. 
Because of the scope of this model, we also omit the individual 
lac operon genes; instead, components representing all lac genes 
and their products are included: lac operon (representing the 
activity of all three genes lacZ, lacY and lacA), lac mRNA (repre-
senting the polycistronic mRNA encoding the three proteins) and 
lac enzymes (representing β-galactoside permease, β-galactoside 
and β-galactoside transacetylase). 
Add ‘lac operon’, ‘lac mRNA’ and ‘lac enzymes’ components 
to the model. You should now have 10 components (Figure 5). 
From the lac operon overview in the Introduction section, we 
can also easily derive the directed edges between the compo-
nents. For example, we know that lactose is converted into al-
lolactose. Add this relationship in Cell Collective by clicking on 
and dragging an edge from ‘lactose’ to ‘allolactose’ (Figure 5). 
The hydrolysis of ‘lactose’ into ‘allolactose’ is abstracted in the 
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model as ‘lactose’ activating ‘allolactose’, depicted with a green 
directed edge. 
Next, we know that when allolactose is produced, it binds to 
the lac repressor, preventing its binding to the lac operator, lift-
ing the repression. This relationship is abstracted in the model 
as ‘allolactose’ inhibiting lac repressor, depicted with a directed 
red edge (Figure 6). To draw an inhibitory edge in Cell Collective, 
create a (positive) edge from ‘allolactose’ to lac repressor and, 
holding the ‘Shift’ key on your keyboard, click on the edge. The 
Figure 5. Adding components and their relationships (edges) in a draft model. 
Orange components correspond to external components, whereas gray compo-
nents— are non-external/internal components—not visualized in this figure. Se-
lected component is denoted in blue. Note that the reader can move components 
around the canvas by pressing the Shift key and move the component around, or 
by switching to the View mode (by clicking on the Pencil icon) and dragging the 
components where needed.    
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resulting inhibitory edge should be red, as indicated in Figure 6. 
(For a list of all keyboard shortcuts, hover over the Information 
‘i’ icon at the top right of the Graph panel.)   
Follow this method to connect all remaining components of 
the model, resulting in the draft model illustrated in Figure 6. 
Step 5: Define and annotate regulatory mechanisms 
Cell Collective facilitates biological knowledge- and context-driven 
creation of logical models and the underlying logic expressions. By de-
sign, users can create models without the direct entry of mathematical 
equations or source code. To define the regulatory mechanism of a 
component in Cell Collective, they select a component’s activator(s) 
and/or inhibitor(s) (direct upstream regulators) and create their more 
complex conditional relationships via the software drag-and-drop user 
interface. 
Figure 6. Fully connected network diagram of the lac operon model. 
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Simple regulatory mechanisms are automatically generated as 
part of the ‘model drawing’ feature. For example, when we drew a 
positive influence between cAMP and CAP in the previous section, 
we also created the underlying logical expression (‘CAP = cAMP’, 
which indicates mathematically CAP (t+1) = cAMP (t)). Similarly, the 
regulatory mechanism of lac operon has also been automatically 
depicted as a logical expression (‘lac operon = CAP AND NOT lac 
repressor’), reflecting the activatory and inhibitory roles of the up-
stream regulators, CAP and lac repressor, respectively (Figure 7). 
Note that in logical models, the simultaneous influences of an ac-
tivator and an inhibitor on a component (such as lac operon in the 
presented model) are expressed by an AND operator to indicate the 
‘opposing influences’ of each component. In a more complex case, 
for example, where multiple activators and inhibitors are present, 
the negative regulators can be defined selectively to work ‘against’ 
specific positive regulators. In Cell Collective, these selections can be 
made under the ‘Dominance’ option in the Regulatory Mechanism 
panel (Figure 7). 
Figure 7. Generation of Boolean expressions. The panel boxed in red shows the 
Boolean function associated with each component, created when developing the 
model in the ‘Graph’ panel (not shown here) or the ‘Regulatory Mechanism’ panel. 
Note that the ‘Expression’ panel is not part of the model workspace by default, but 
users can add it by clicking on Insert ->Panel ->Model ->Regulation Expression at 
the top of the page (under the model name).    
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Additional, more complex regulatory mechanisms involving, for in-
stance, conditional relationships among multiple upstream regulators, 
can be easily defined in the ‘Regulatory Mechanism’ panel (Figure 8). 
An example would be the requirement of a cofactor for a transcription 
factor to initiate the transcription of a gene. Cell Collective represents 
such relationships as ‘conditions’. As illustrated in Figure 8, the ‘tran-
scription factor’ would be defined as an activator of the gene, and 
only activate gene if co-factor is active. Note that even more complex 
conditional relationships can be defined, with multiple conditions, as 
well as conditions of conditions (sub-conditions), depending on the 
complexity of the underlying regulatory mechanism [33].   
A critical, and often overlooked, part of developing computational 
models is annotation. Well annotated models facilitate transpar-
ency and reusability [56, 57]. Cell Collective allows the annotation of 
components at multiple levels, including the model, the regulatory 
mechanism of a component, and individual interactions. Model-level 
annotations contain general model information, such as its scope and 
the validation criteria, to help the community understand if and how 
it may be used as a starting point for their research questions. Users 
can add model annotations in the ‘Description’ tab. They can add 
Figure 8. Drag-and-drop components to build the regulatory mechanism of a given 
component. To define the regulatory mechanism of a given component, drag com-
ponents from the ‘Internal/External Components’ panels to the corresponding areas 
in the ‘Regulatory Mechanism’ panel. 
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more detailed annotations at the level of each component’s regula-
tory mechanism and interactions during the model-building process 
in the ‘Knowledge Base’ (KB) panel (Figure 9). In the KB panel, users 
can describe the meaning of each component of the model while 
providing unique identifiers when available. For instance, they can 
describe individual interactions (e.g. the activation of CAP by cAMP) 
at the level of biochemical and mechanistic regulation, while providing 
published evidence to support the mechanism. 
Step 6: In silico model validation and predictions 
Once all the regulatory mechanisms and corresponding logical expres-
sions for each component of the model are defined, we can simulate 
Figure 9. Annotations of components and interactions in Cell Collective. The KB 
panel (boxed in red) enables users to provide detailed information about each 
model component and its immediate regulating interactions. Each piece of text, or 
evidence, is citable with a PMID or DOI, allowing to connect each piece of support 
to its underlying sources. Furthermore, by right-clicking on the citation or reference, 
the user can specify if the source is primary or non-primary (e.g. a review article) 
source, and whether the support (data) in the source comes from human or animal 
experiments.     
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the model to test whether it can reproduce the dynamics and behav-
iors defined in the validation criteria. As the rules are assigned locally, 
there is no guarantee that the global behavior will comply with those 
criteria or the descriptions in the published literature. Users should 
expect several revisions of regulatory mechanisms, rules, re-wiring 
and, possibly, additions or deletions of components and edges while 
fine-tuning the model.    
Cell Collective offers several simulation tools to interrogate and 
visualize the dynamics of a model interactively and in real time. Al-
though models in Cell Collective are Boolean as discussed in the Step 
3, inputs and outputs are semi-quantitative during the simulations, 
to describe the relative activity of a particular model component in 
response to environmental signals or perturbations in the model [1, 
2, 58]. Users can define the activity levels of external components 
(inputs) on a scale from 0 to 100, representing the percent chance 
of the external component to be active or inactive at any time dur-
ing the simulation. The overall activity of any internal component or 
output of the model spans the same scale, representing the average 
activity (fraction of ones) over a defined number of previous time 
steps. For example, if a component has an activity level of 50%, it 
means that the component assumed the same number of active and 
inactive states over the last n number of iterations, likened to the 
concept of ‘moving average’. The number of iterations is defined 
with the ‘Sliding Window’ parameter in the real-time simulation fea-
ture (Procedure 3) [39].While the values of inputs (e.g. glucose set to 
90%) do not directly correspond to a specific, measurable biologi-
cal property (such as concentration), users can interpret the activity 
levels semi-quantitatively [39, 59]. For example, they can represent 
‘high amounts of glucose in the environment’ by setting glucose 
activity to 80–100% and ‘low amounts of environmental glucose’ 
by setting it to 0–10%. Cell Collective can simulate dose–response 
experiments and show how components’ dynamics evolve when the 
activity of inputs increases. 
In the Procedure 3 box, we illustrate how to simulate the four vali-
dation criteria (Table 1) to assess the usefulness of the model using 
Cell Collective’s real-time and dose–response simulation tools. 
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Procedure 3: Model validation. 
Criterion 1: Lactose metabolism should be inactive when glucose 
is present and lactose is absent from the environment. 
Access the real-time simulation workspace under the ‘Simula-
tion’ tab in your model in Cell Collective. 
Ensure Simulation Control Settings (Figure 10A) are config-
ured to. 
Simulation Speed = 1. 
Sliding Window= 10. 
Define the Environment of the model in the External Compo-
nents panel (Figure 10B) by adding glucose: 
Figure 10. Real-time simulation of the lac operon model under a high-glucose, 
no lactose environment. The activity levels of all components of the model are il-
lustrated in the ‘Activity Network’ panel (C) with colors of the component ranging 
from red (0) to green (100) and in the ‘Simulation Graph’ panel (D) as a time-series 
graph, which shows the activity levels of selected components over time. Note 
that the time scale is arbitrary, measured in time steps. Components to be viewed 
in the ‘Simulation Graph’ panel can be added by clicking on the components in 
the network or by checking the first column in the ‘Internal/External Components’ 
tables.   
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Adjust the ‘glucose’ slider to 100, which will simulate the avail-
ability of glucose during each step of the simulation. 
Ensure that the ‘lactose’ slider is set to 0, which will simulate 
complete absence of lactose from the environment. 
To view ‘lactose metabolism’ as the measured variable (out-
put) of the model click on the component in the Activity Net-
work panel (Figure 10C). This will add ‘lactose metabolism’ to 
the Simulation Graph panel (Figure 10D). We can also observe 
the dynamics of other components of the model, by clicking, for 
example, on lac operon, CAP and lac repressor. 
Start the simulation by clicking on the play (◮) button under 
the Simulation Control panel. 
Click the pause (||) button after ~75 steps (shown on the x-axis). 
The activity of each component can be observed in the Simula-
tion Graph panel as it evolves in time. To see specific components 
in the graph, hover the cursor over the component name in the 
legend. Furthermore, the Activity Network panel shows the ac-
tivity levels of all components in the network as colored nodes, 
where bright green corresponds to complete (100%) activation 
and red corresponds to a complete absence of activation (0%). 
Shades of these colors correspond to activity levels between 0 
and 100. 
Simulation result—Under this environmental condition (where 
glucose is present and lactose is absent), you should observe that 
‘lactose metabolism’ is inactive, as expected (Figure 10D). 
Validation Criteria 2–4. 
Continue to simulate the model (press (◮) button) under the 
remaining three environmental conditions, by moving the glucose 
and lactose sliders between 0 and 100. You can also set the slid-
ers to intermediate values to observe partial activation responses 
within the system. 
The response of a model output or various components can be 
simulated in Cell Collective using the Dose Response tool un-
der the ‘Analysis’ tab as illustrated in Figure 11. 
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Predicting the effect of mutations and modulators 
When we are satisfied with the model structure and its ability to re-
produce the defined validation criteria, we can use it for performing 
additional in silico experiments to develop new hypotheses or refine 
existing ones. For example, one can simulate perturbations of the 
system by constitutively inactivating components, thus generating in 
silico knock-outs, simulate inhibitions or overexpressions and make 
specific predictions before testing them at the bench. One of the ad-
vantages of computational models is the possibility to easily simulate 
the systematic effects of individual or combinatorial perturbations 
of many components of the model. Examples are reviewed in [2, 58, 
60–63]. 
Figure 11. Dose–response curve analysis of lactose metabolism under lactose 
varying conditions. Glucose is absent from the environment. Instead of selecting 
a single activity level of the input, users can select a range of activities by adding 
new Environments under the ‘External Components’ panel (B). Here, Glucose is set 
to 0, and Lactose varies from 0 to 100. Make sure that the appropriate environment 
is selected in the ‘Experiment Settings’ panel (A). The components represented 
on the y- and x-axes can be selected by checking appropriate boxes in the ‘Graph 
Components’ panel (C). 
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We can test different scenarios on the lac operon model, such 
as the effects of mutations on the system’s dynamics. For instance, 
Procedure 4 shows simulations of the effects of CAP loss-of-func-
tion on lactose metabolism under environmental conditions condu-
cive to lac operon expression. 
Procedure 4: Simulating the effects of CAP loss of function 
on lactose metabolism. 
In Cell Collective, mutations (knock-out and overexpression) can 
be introduced by checking the box next to a component of in-
terest in the ‘Internal Components’ panel within the ‘Simulation’ 
workspace (Figure 12). 
Check the box next to CAP such that the check-mark is red, 
indicating a knock-out mutation. Clicking on the box twice will 
add a green check-mark, indicating an overexpression and click-
ing on the box for the third time will uncheck the box, returning 
Figure 12. Real-time simulation of effects of CAP knock-out mutation.  
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the corresponding component to its wild-type status. 
Set the environmental condition that is conducive to lac op-
eron expression by setting extracellular glucose and lactose to 
appropriate levels of 0 and 100, respectively. 
Select the components whose activity you would like to ob-
serve in the ‘Simulation Graph’ panel by clicking on them in the 
network diagram. Because we are interested in observing the ef-
fects of ‘CAP’ loss-of-function on lactose metabolism, select the 
‘CAP’ and ‘lactose metabolism’ components. 
Start the simulation. After ~50–60 steps, we can observe that, 
while ‘allolactose’ and ‘cAMP’ reach 100%, ‘CAP’, lac enzymes, 
lac mRNA, lac operon, lac repressor and ‘lactose metabolism are 
entirely inactive. The simulation recapitulates the dynamic behav-
ior of the system in a scenario where the hunger signal, cAMP, 
is active due to the absence of ‘glucose’, and ‘allolactose’ is ac-
tive because of the presence of extracellular ‘lactose’. ‘Allolactose’ 
subsequently binds and activates the lac repressor. However, the 
‘CAP’ loss-of-function mutation precludes the binding of ‘CAP’ to 
the DNA and the subsequent recruitment of the RNA polymerase. 
The lac operon thus remains inactive, no lac enzymes are trans-
lated and no lactose metabolism takes place.  
While the previous example illustrated the simulation of complete 
knock-out/loss-of-function mutations, partial mutations, such as 
knock-down/down-regulation or overexpression, can also be simu-
lated. We do so by adding an external component that will inhibit or 
activate the component whose expression we want to perturb. Users 
can subsequently set the activity of the newly introduced external 
component to the desired value. Procedure 5 illustrates this concept. 
Procedure 5: Partial in silico mutations. 
Add a new external component, CAP Inhibitor, to the Lac operon 
model. 
Add an inhibitory edge from ‘CAP Inhibitor’ to ‘CAP’. 
To simulate the effect of partial inhibition of ‘CAP’ using the 
real-time simulation tool, change the activity levels of ‘CAP Inhibi-
tor’ and select ‘CAP’, ‘CAP Inhibitor’ and ‘lactose metabolism’ as 
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variables to observe during the simulation. Start the simulation 
(not pictured). 
Dose response (Figure 13): To simulate a dose–response of 
lactose metabolism to ‘CAP Inhibitor’, go to the dose response 
analysis tool, under the ‘Analysis’ tab. 
In the ‘Experiment Settings’ add a new experiment. 
In the ‘External Components’ panel (B), set ‘glucose’ to range 
from 0 to 5%, ‘CAP Inhibitor’ to range from 0 to 100% and lactose to 
range from 90 to 100%. Notice that a new environment, called ‘New 
Env 1’, is created, accessible in the header of the ‘External Compo-
nents’ panel. Rename it to ‘Inhibitor’ by clicking on the name. 
Under the ‘Experiments Settings’ panel (A), change the Envi-
ronment from ‘Default’ to the one created in the previous step, 
‘Inhibitor’. 
In the ‘Graph Components’ panel (D), select ‘CAP Inhibitor’ for 
the x-axis and ‘lactose metabolism’ for the y-axis. 
Start the experiment in the ‘Experiment Settings’ panel (A). 
The dose–response will be plotted in the ‘Activity Relationships 
Graph’ panel (C). 
Figure 13. Dose–response curve of CAPInhibitor and its effect on lactose metabo-
lism under high-lactose and low-glucose environments. (A) Experiment Settings 
panel. (B) External Components panel. (C) Activity Relationships panel. (D) Graph 
Components panel.   
Niarakis  & Hel ikar in Brief ings in B ioinformatics  2020     28
Reachability and control of biological systems 
So far, we have presented procedures where users set initial con-
ditions and observe the—a priori unknown—results of simulations. 
However, computational models also lend themselves to study where 
one wants to know which conditions must be met for the model to 
reach a known result, such as ‘under what extracellular conditions is 
the activity of component X maximal?’ To illustrate this type of analysis 
with our model, we will try to answer the following question ‘Under 
what levels of lactose and glucose can we get the highest levels of 
lactose metabolism?’  
To address such questions pertaining to the sensitivity of a system 
towards the environment in Cell Collective, we use the ‘Environment 
Sensitivity’ workspace in the ‘Analysis’ tab. Follow the instructions illus-
trated in Procedure 6 to conduct the environment sensitivity analysis. 
Procedure 6: Reachability and environment sensitivity 
analysis. 
In the lac operon model in Cell Collective, access the Environment 
Sensitivity workspace via the Analysis tab (Figure 14). 
In the ‘Experiments’ panel (Figure 14A), add a new experiment, 
named ‘Sensitivity Analysis’. 
To consider all possible environmental input combinations, 
create a new environment in the ‘External Components’ panel 
(Figure 14B),where ‘glucose’ and ‘lactose’ vary from 0 to 100, 
while setting ‘CAP Inhibitor’ to 0. Name the environment ‘Sen-
sitivity’. To limit the possible environments, choose alternative 
ranges to suit your needs.    
In the ‘Internal Components’ panel (Figure 14E), select ‘lactose 
metabolism’ and change the ‘Optimize’ column (two vertical op-
posite arrows) to a green, upward arrow, to tell the software we 
want to maximize the activity level of ‘lactose metabolism’ under 
the selected range of environmental inputs. 
In the ‘Experiments Settings’ panel (Figure 14D), change the 
Environment to ‘Sensitivity’. Change the number of Simulations 
to 1000. 
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Start the experiment in the ‘Experiment Settings’ panel. 
The ‘Environment Sensitivity’ panel (Figure 14F) will generate 
an environmental condition in the context of activity levels of 
‘lactose’ and ‘glucose’ that will result in high levels of ‘lactose me-
tabolism’. The ‘Component Sensitivity’ panel (Figure 14C) shows 
the effect size that each input has on ‘lactose metabolism’. In 
particular, the results show that ‘glucose’ has an overall negative 
effect on ‘lactose metabolism’, while ‘lactose’ has a positive effect 
on ‘lactose metabolism’. Results from this analysis are consistent 
with the simulations and analyses conducted in the previous sec-
tions: ‘lactose metabolism’ will be the most active under high 
lactose and low/no glucose conditions. 
Figure 14. Environment sensitivity analysis.    
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State-space and attractors 
Another layer of analyses of computational models includes the ex-
ploration of the entire space of states that a model can find itself in as 
a result of its environmental stimuli or various perturbations. Because 
each component of a Boolean network can take the values 0 or 1, 
the entire model can exist in at most 2n different states. Using either 
synchronous or asynchronous updates (see Box 1) and fixed inputs 
(e.g. ‘lactose’ and ‘glucose’ set to 0 or 1 for the entirety of the simula-
tion), the dynamics of a logical model will eventually lead to a set of 
states from which it cannot leave, called an ‘attractor’. Attractors can 
be either stable states (states from where our system cannot escape 
without external intervention), representing, for example, cell fates 
(apoptosis, cell differentiation, or in our case active or inactive ‘lactose 
metabolism’) or more complex attractors, for instance, representing 
oscillatory behaviors [36]. An attractor can be considered as represent-
ing a stable and long-term behavior of the modeled system. In this 
section, we will use the GINsim software tool to illustrate the analysis 
of state-space and attractors for the lac operon [41]. Follow Procedure 
7 to import the Cell Collective lac operon model and perform steady-
state analysis in GINsim. 
Procedure 7: Importing the model in GINsim and perform-
ing steady-state analysis. 
Export the Lac operon model from Cell Collective in the SBML-
qual format [53, 54]. Under your Lac operon model in Cell Col-
lective, click on File ->Download ->SBML. 
Open GINsim and from the Start menu select New Model. 
Then, click on File ->Import. Select SBML-qual from the Import 
options. 
Select ‘Show it’ in the subsequent preprocessing panel. 
Rename the model to ‘beta_gal_ginsim’ in the Name textbox. 
You can adjust the network model layout by moving the in-
dividual components or by selecting built-in layouts from the 
menu (View). 
Select Tools ->Compute Stable States (Figure 15).  
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A second panel will open where the user can choose optional 
model reduction or specify perturbations. Press Run to compute 
all possible steady states of the model. 
Figure 15. Computing stable states of the model using GINsim. 
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A table with a summary of the steady states of the model will 
be displayed once the computation finishes (Figure 16). Results 
show that the lac operon is ON when lac repressor is absent, lac-
tose is present and glucose is absent. These results align with the 
validation criteria (Table 1) and with the Cell Collective simulation 
results discussed earlier. 
Adding nodes or reactions to a model can change the reachable 
states. Figure 17 shows the stable states computed when we add 
‘CAP inhibitor’.  
Figure 16. Calculating all possible stable states for the lac operon model, com-
puted with the software GINsim. Value 1 represents the ON state (also correspond-
ing to 100% activity level in Cell Collective).   
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Procedure 8: Adding nodes to the model in GINsim. 
In GINsim, select               to add a new component to the model. 
Then, add the name of the component to the Id box in the bot-
tom left panel: 
Select              to add the inhibition from CAP inhibitor to CAP. 
Proceed as explained in Procedure 7 to compute stable states. 
Figure 17. Adding nodes to the model will result in different dynamics and different 
set of stable states. The addition of the CAP inhibitor resulted in four more stable 
states of the model. The lac operon will be ON only in the absence of CAPs inhibitor, 
and when glucose is absent.   
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The addition of the ‘CAP inhibitor’ resulted in four more stable 
states of the model. We see that the lac operon is ON only in the 
absence of ‘CAP inhibitor’, and when ‘glucose’ is absent, which cor-
responds to our biological knowledge about the CAP mechanism of 
action. 
Step 7: Wet-lab validation 
The observations resulting from the procedures illustrated above 
might generate new hypotheses regarding the modeled system, which 
can be validated experimentally. A validated prediction means that us-
ing the model generated a reliable hypothesis, potentially saving time 
and valuable resources. An invalidated prediction can still stimulate 
further investigations of the modeled system by, for example, revisit-
ing the model to identify gaps in its structure, its parametrization or 
the simulation and analysis procedures. 
The scope of the model, for example the level of abstraction (e.g. 
cellular or molecular), modeling approach and the type of data gen-
erated from the model will provide a starting point on how the 
model predictions can be further validated using wet-lab experi-
mentation. In the case of logical models, Cell Collective has been 
used to investigate the qualitative impact of perturbations on the 
activity of various parts of the network. For example a logical model 
of signal transduction in T cells was used to predict the role and 
impact of the knock-out and overexpression of Caveolin-1 (an im-
portant scaffold protein) on T cell signaling [60]. The output of Cell 
Collective—differential activity levels of all model components under 
normal and perturbed conditions—was subsequently validated in an 
in vivo mouse model using differential gene expression analysis and 
qualitative immunochemistry—output of which can be intuitively 
connected with the logical model predictions. Another recent study 
highlights the potential of mechanistic modeling in precision medi-
cine [29]. In particular, ex vivo high-throughput screening of pan-
creatic cancer samples was used to generate patient-specific logical 
models. In this study, the model output (similar to Cell Collective 
output) was continuous, enabling the measure of perturbation effect 
on the activity level of other network components. These models 
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were, in turn, used to predict the effect of 174 combinatorial per-
turbations on cancer-specific pathways, measured as activity level of 
the pathway components. The authors subsequently validated three 
most highly ranked predicted combinatorial perturbations on cancer 
cell lines and mouse models. As introduced in the previous section, 
logical models can be analyzed to identify attractors— stable sets 
of states—that can, for example, represent and correspond to cell 
phenotype. An intuitive example of such utility is the study of cell 
differentiation. In particular, the binary activity of transcription fac-
tors in a given attractor can be associated with the realization of a 
specific cell fate. For example, authors analyzed with GINsim, the 
state space of a logical model of signal transduction network gov-
erning the differentiation of CD4+ T cells into effector T cells, and 
identified attractors with new patterns of transcription factor activity, 
effectively predicting novel T cell phenotypes [64]. Such phenotypes 
can be further validated with well-established T cell differentiation 
assays and molecular techniques used to identify T cell (sub-)popula-
tions involving, for example, the detection of expression of specific 
transcription factors [65]. 
Timing and anticipated results 
Following the entire protocol, as described above, takes ~3 h. Apply-
ing the protocol to model other biological processes will of course 
change this timing, depending on the size and complexity of the 
system to model, the availability (and comprehensiveness) of re-
sources with synthetic knowledge about the system’s components 
(review articles, pathway databases, etc.). This protocol will result in 
a mechanistic (logical) model of the lac operon regulatory system 
that can serve as a starting point for the reader to expand the model 
further and, using the newly acquired knowledge, to build models 
of other biological systems. A version of the model described in the 
protocol, encoded in the SBML-qual format [66, 67], is provided as 
Supplementary File 1. The reader can use it as the ‘answer key’ in 
case their modeling outputs do not match the outputs presented 
in the protocol. 
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Conclusions 
Herein, we describe a generalized step-by-step approach to abstract-
ing, representing and simulating a biological system in the form of 
a mechanistic computational model. We contextualized the proto-
col within a well-characterized gene regulatory system—the lac op-
eron. The protocol can be applied to other biological systems and 
processes. The protocol also introduces Cell Collective, a web-based 
modeling platform with a user-friendly interface (without the need to 
write complex mathematical equations or computer code) for con-
structing, annotating and simulating/analyzing the model. One of the 
important advantages is that the user can perform real-time analy-
ses and simulations testing different hypotheses. We also illustrated 
how the constructed model can be used to recapitulate the known 
dynamics of the system and study the effect of mutations on the lac 
operon system. In the last part of the protocol, we used the software 
GINsim to complete the analysis by calculating the stable states of the 
model. We hope that this protocol will make computational systems 
modeling more approachable while allowing readers to identify and 
utilize fundamental modeling aspects that they can immediately begin 
utilizing in his/her system of interest. 
More complex model representation of the lac operon system 
At the beginning of this practical guide, we discussed the importance 
of selecting and understanding the model’s scope. For this guide’s 
purpose, we decided that the model would include glucose and lac-
tose regulating lactose metabolism through relatively simple path-
ways. A computational model of a broader scope would be needed to 
explore more complex aspects of the lac operon system. For example, 
one could model inducer exclusion— a phenomenon whereby glucose 
can inhibit the transport of extracellular lactose by the lac permease 
(in addition to catabolite repression) [20, 21]. 
In addition, the lac operon can exhibit bi-stability, in the sense that 
it can exist in two states: induced and uninduced [68– 73]. A system is 
called bi-stable if it can rest in two distinct stable states, e.g. operon 
induced and operon not induced. Some bi-stable systems can also 
present switch-like behavior, enabling them to alternate between the 
Niarakis  & Hel ikar in Brief ings in B ioinformatics  2020      37
two stable states. For example, when external lactose is transported 
into the cell, it is converted into allolactose. Allolactose subsequently 
induces the operon, causing the synthesis of more permease mol-
ecules that can transport more external lactose, which is then con-
verted into more allolactose. Several studies have been published 
concerning the bi-stability of the lac operon, and several models have 
been developed addressing this issue. Examples of models of the 
lac operon system with a larger scope focus on diauxic growth [20], 
feedback regulation [72], bi-stability as well as the effects of catabolite 
repression and inducer exclusion in the lac operon [68], or a more 
detailed Boolean model by Veliz-Cuba and Stigler [71], also avail-
able in Cell Collective (ModeID 5128; https://research.cellcollective.
org/?dashboard=true#5128:1/lacoperon/1).  
Key Points 
• The described guide will help researchers begin incorporat-
ing mechanistic computational modeling into their research 
inquiries. 
• Readers will be able to define the scope and validation criteria 
of the desired model. 
• Non-experts will be able to quickly begin building, simulating 
and (computationally) validating their models. 
• We hope this guide will make mechanistic computational 
modeling more accessible to a broad range of scientists and 
teachers. 
Disclosure statement  Dr. Helikar is a majority stakeholder and has served as a 
scientific advisor and/or consultant to Discovery Collective, Inc. 
Funding National Institutes of Health (grant no. 1R35GM119770–04) to T.H. 
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